Literature DB >> 23856332

Vaccine effects and impact of vaccination programmes in post-licensure studies.

Germaine Hanquet1, Marta Valenciano, François Simondon, Alain Moren.   

Abstract

Once a vaccine is licensed and introduced in the population, post-licensure studies are required to measure vaccine effectiveness and impact of vaccination programmes on the population at large. However, confusion still prevails around these concepts, making it difficult to discern which effects are measured in such studies and how their findings should be interpreted. We review from the public health evaluation perspective the effects of vaccine-related exposures, describe the methods used to measure them and their assumptions. We distinguish effects due to exposure to individual vaccination from those due to exposure to a vaccination programme, as the latter depends on vaccine coverage, other population factors and includes indirect effects as well. Vaccine (direct) effectiveness is estimated by comparing vaccinated and unvaccinated individuals exposed to the same vaccination programme. The impact of a vaccination programme, defined here as the population prevented fraction when exposure is the programme, is measured by comparing populations with and without a vaccination programme, most commonly the same population before and after vaccination. These designs are based on a number of assumptions for valid inference. In particular, they assume that vaccinees and non-vaccinees do not differ in terms of susceptibility and exposure to the disease or in ascertainment of vaccination and disease status. In pre and post-vaccination design, the population is assumed to have similar baseline transmission, case detection and reporting, risk factors and medical practices in both periods. These principles are frequently violated in post-licensure studies. Potential confounding and biases must be minimized in study design and analyses, or taken into account during result interpretation. It is also essential to define which exposure is evaluated (individual vaccination or vaccination programme) and which effect is measured. This may help decision-makers clarify which type of study is needed and how to interpret the results.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Keywords:  Epidemiology; Impact; Observational studies; Vaccination; Vaccine effectiveness

Mesh:

Substances:

Year:  2013        PMID: 23856332     DOI: 10.1016/j.vaccine.2013.07.006

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  45 in total

1.  Assessing sociodemographic differences in human papillomavirus vaccine impact studies in the United States: a systematic review using narrative synthesis.

Authors:  L R Avni-Singer; A Yakely; S S Sheth; E D Shapiro; L M Niccolai; C R Oliveira
Journal:  Public Health       Date:  2019-11-04       Impact factor: 2.427

2.  Incidence of varicella and herpes zoster after inclusion of varicella vaccine in national immunization schedule in Turkey: time trend study.

Authors:  Ahmet Soysal; Erdem Gönüllü; İsmail Yıldız; Metin Karaböcüoğlu
Journal:  Hum Vaccin Immunother       Date:  2020-07-23       Impact factor: 3.452

Review 3.  Varicella vaccination - the global experience.

Authors:  Peter Wutzler; Paolo Bonanni; Margaret Burgess; Anne Gershon; Marco Aurélio Sáfadi; Giacomo Casabona
Journal:  Expert Rev Vaccines       Date:  2017-07-13       Impact factor: 5.217

4.  Evaluation of the Real-World Effectiveness of Vaccines against COVID-19 at a Local Level: Protocol for a Test-Negative Case-Control Study.

Authors:  Cátia Brazete; Marta Pinto; Lígia Sá; Ana Aguiar; Filipe Alves; Raquel Duarte
Journal:  Vaccines (Basel)       Date:  2022-05-23

5.  CHEMOPROPHYLAXIS TO CONTROL LEPROSY AND THE PERSPECTIVE OF ITS IMPLEMENTATION IN BRAZIL: A PRIMER FOR NON-EPIDEMIOLOGISTS.

Authors:  Sergio Souza da Cunha; Ana Luiza Bierrenbach; Vitor Hugo Lima Barreto
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015-12       Impact factor: 1.846

6.  Impact and effectiveness of a conjugate vaccine against invasive pneumococcal disease in Finland - a modelling approach.

Authors:  Hanna Rinta-Kokko; Markku Nurhonen; Kari Auranen
Journal:  Hum Vaccin Immunother       Date:  2020-12-17       Impact factor: 3.452

7.  Exposure misclassification bias in the estimation of vaccine effectiveness.

Authors:  Ulrike Baum; Sangita Kulathinal; Kari Auranen
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

8.  Signals of hope: gauging the impact of a rapid national vaccination campaign.

Authors:  Smadar Shilo; Hagai Rossman; Eran Segal
Journal:  Nat Rev Immunol       Date:  2021-04       Impact factor: 53.106

9.  Using observational epidemiology to evaluate COVID-19 vaccines: integrating traditional methods with new data sources and tools.

Authors:  Catharine Chambers
Journal:  Can J Public Health       Date:  2021-06-23

10.  COVID-19 vaccinations are associated with reduced fatality rates: Evidence from cross-county quasi-experiments.

Authors:  Li-Lin Liang; Hsu-Sung Kuo; Hsiu J Ho; Chun-Ying Wu
Journal:  J Glob Health       Date:  2021-07-17       Impact factor: 4.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.